Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1CNS 1

Conditions

Breast Neoplasms 3494Neoplasms 2740Prostatic Neoplasms 1582Colorectal Neoplasms 1247Lung Neoplasms 1187Motor Activity 764Head and Neck Neoplasms 620Pancreatic Neoplasms 601Colonic Neoplasms 586Uterine Cervical Neoplasms 566Carcinoma, Non-Small-Cell Lung 559Carcinoma, Hepatocellular 558Rectal Neoplasms 516Stomach Neoplasms 493Brain Neoplasms 436Anxiety Disorders 401Ovarian Neoplasms 397Pain 375Esophageal Neoplasms 347Neoplasm Metastasis 340Polycystic Ovary Syndrome 339Fatigue 324Urinary Bladder Neoplasms 314Precursor Cell Lymphoblastic Leukemia-Lymphoma 303Melanoma 298Depression 286Multiple Myeloma 282Endometrial Neoplasms 262Lymphoma 258Hematologic Neoplasms 251

Interventions

Rivaroxaban 1Long-Term Synaptic Depression 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × OTHER × Dyskinesias × Clear all
NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Nanfang Hospital, Southern Medical University

Phase NA Unknown
320 enrolled
CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡